Haleon plc Market Cap ($40.25 Billion)
Market Cap & Net Worth: Haleon plc (HLN)
Haleon plc market cap. Haleon plc (NYSE:HLN) has a market capitalization of $40.25 Billion ($40.25 Billion) as of November 8, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #654 globally and #315 in its home market, demonstrating a 6.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haleon plc's stock price $9.14 by its total outstanding shares 4403863311 (4.40 Billion). Also see cash efficiency ratio of Haleon plc for how efficiently the company converts equity into cash flow.
Haleon plc Market Cap History (2022–2026)
Haleon plc market cap history from 2022 to 2026. Data shows growth from $34.17 Billion to $40.25 Billion (5.44% CAGR). Check HLN live share price for real-time trading data and today's change.
Haleon plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Haleon plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HLN year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.04x
Haleon plc's market cap is 4.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.31x
Haleon plc's market cap is 27.31 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $34.17 Billion | $10.86 Billion | $1.06 Billion | 3.15x | 32.24x |
| 2023 | $35.61 Billion | $11.30 Billion | $1.05 Billion | 3.15x | 33.95x |
| 2024 | $42.01 Billion | $11.23 Billion | $1.44 Billion | 3.74x | 29.14x |
| 2025 | $44.52 Billion | $11.03 Billion | $1.63 Billion | 4.04x | 27.31x |
Competitor Companies of HLN by Market Capitalization
Companies near Haleon plc in the global market cap rankings as of November 8, 2026. Also see Haleon plc assets under control for a full breakdown of the balance sheet.
Key companies related to Haleon plc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Galderma Group N (SW:GALD): Ranked #718 globally with a market cap of $37.01 Billion USD ( CHF29.28 Billion CHF).
- Zoetis Inc (NYSE:ZTS): Ranked #756 globally with a market cap of $34.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #718 | Galderma Group N | SW:GALD | $37.01 Billion | CHF191.75 |
| #756 | Zoetis Inc | NYSE:ZTS | $34.99 Billion | $79.40 |
Market Capitalization of Haleon plc (2022–2026)
Market capitalization of Haleon plc from 2022 to today. Between 2022 and today, Haleon plc's market cap moved from $34.17 Billion to $ 40.25 Billion, with a yearly change of 5.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.25 Billion | -9.59% |
| 2025 | $44.52 Billion | +5.97% |
| 2024 | $42.01 Billion | +17.97% |
| 2023 | $35.61 Billion | +4.21% |
| 2022 | $34.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Haleon plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.25 Billion USD |
| MoneyControl | $40.25 Billion USD |
| MarketWatch | $40.25 Billion USD |
| marketcap.company | $40.25 Billion USD |
| Reuters | $40.25 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more